EGFR-mutant Lung Cancers
1 clinical trials · Condition
◉ Watch EGFR-mutant Lung Cancers
| Record | Firm | Date |
|---|---|---|
| Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers (NCT02803203) | Memorial Sloan Kettering Cancer Center | 2016-06-29 |
Track EGFR-mutant Lung Cancers automatically
Every clearance here is in the API, with alerts when new ones post.